Join a dedicated Spatial Biology community where meaningful connections thrive, backed by longstanding partnerships with leaders like Roche Diagnostics and Flagship Biosciences

The spatial biology market is projected to grow at an impressive overall rate of 27.8% between 2024 and 2031, with oncology emerging as the leading growth area within this expanding field. As precision medicine becomes the standard of care, the integration of spatial biology technologies will be essential for understanding tumor heterogeneity and guiding personalized treatment strategies.

You could have capitalized on this momentum by elevating your brand and showcasing your pioneering solutions at the 3rd Spatial Biology for Immuno-Oncology Summit. As a sponsor, you would have gained exclusive access to an audience of industry leaders eager to explore the advanced spatial technologies that are reshaping cancer research. You would have collaborated with VPs, Directors and Heads of Departments in pharma and biotech to demonstrate how your innovations can enhance the understanding of tumor biology and driven breakthroughs in therapeutic strategies. This was an opportunity to position yourself at the forefront of a movement that is transforming the landscape of immuno-oncology.